Literature DB >> 3875685

Prevalence of treated and untreated DSM-III schizophrenia. Results of a two-stage community survey.

M Von Korff, G Nestadt, A Romanoski, J Anthony, W Eaton, A Merchant, R Chahal, M Kramer, M Folstein, E Gruenberg.   

Abstract

Psychiatrists, using a standardized clinical method, examined a probability sample of 810 subjects in eastern Baltimore and made diagnoses of mental disorders among those subjects according to DSM-III criteria. The authors estimated that there were 4.6 active cases of schizophrenia per 1000 adult noninstitutionalized population, and 6.4 cases per 1000 population, including both active and remitted cases. Among the 17 active and remitted schizophrenics identified in the survey, one half were not receiving any form of mental health services at the time of the survey; these data yield a prevalence rate of untreated cases of 3.1 per 1000 population. All of the untreated schizophrenics were deemed by the examining psychiatrist to be in need of services.

Entities:  

Mesh:

Year:  1985        PMID: 3875685     DOI: 10.1097/00005053-198510000-00001

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  10 in total

Review 1.  Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature.

Authors:  Julie Kreyenbuhl; Ilana R Nossel; Lisa B Dixon
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306

2.  First admission rates for schizophrenia in immigrants to The Netherlands. The Dutch National Register.

Authors:  J P Selten; N Sijben
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-04       Impact factor: 4.328

3.  Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?

Authors:  Dennis K Kinney; Pamela Teixeira; Diane Hsu; Siena C Napoleon; David J Crowley; Andrea Miller; William Hyman; Emerald Huang
Journal:  Schizophr Bull       Date:  2009-04-08       Impact factor: 9.306

4.  Occupational characteristics and the occurrence of psychotic disorders.

Authors:  C Muntaner; A Y Tien; W W Eaton; R Garrison
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1991-12       Impact factor: 4.328

5.  Predictability of rehospitalization for schizophrenia.

Authors:  J M Haro; W W Eaton; W B Bilker; P B Mortensen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 6.  An economic evaluation of schizophrenia--1991.

Authors:  R J Wyatt; I Henter; M C Leary; E Taylor
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-08       Impact factor: 4.328

7.  The Italian SEME Surveillance System of Severe Mental Disorders Presenting to Community Mental Health Services.

Authors:  Antonella Gigantesco; Ilaria Lega; Angelo Picardi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-02-24

8.  The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: findings from the multinational EU-GEI study.

Authors:  Fabian Termorshuizen; Els van der Ven; Ilaria Tarricone; Hannah E Jongsma; Charlotte Gayer-Anderson; Antonio Lasalvia; Sarah Tosato; Diego Quattrone; Caterina La Cascia; Andrei Szöke; Domenico Berardi; Pierre-Michel Llorca; Lieuwe de Haan; Eva Velthorst; Miguel Bernardo; Julio Sanjuán; Manuel Arrojo; Robin M Murray; Bart P Rutten; Peter B Jones; Jim van Os; James B Kirkbride; Craig Morgan; Jean-Paul Selten
Journal:  Psychol Med       Date:  2020-09-22       Impact factor: 10.592

Review 9.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

10.  Predictors of Dropout from Outpatient Mental Health Services; A Study from Rohtak, India.

Authors:  Nikhil Jain; Sidharth Arya; Rajiv Gupta
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.